Pure Financial Advisors, LLC Eli Lilly & CO Transaction History

Pure Financial Advisors, LLC

$3.51 Billion
Q2 2024

A detailed history of Pure Financial Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Pure Financial Advisors, LLC holds 5,284 shares of LLY stock, worth $4.8 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

5,284

Previous 5,399 2.13%

Holding current value

$4.8 Million

Previous $4.2 Million 13.9%

% of portfolio

0.14%

Previous 0.13%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$724.87 - $909.04 $83,360 - $104,539	-115 Reduced 2.13%	5,284 $4.78 Million
Q1 2024 Apr 16, 2024	BUY	$592.2 - $792.28 $608,189 - $813,671	1,027 Added 23.49%	5,399 $4.2 Million
Q4 2023 Jan 08, 2024	SELL	$525.19 - $619.13 $68,274 - $80,486	-130 Reduced 2.89%	4,372 $2.55 Million
Q3 2023 Oct 10, 2023	BUY	$434.7 - $599.3 $319,069 - $439,886	734 Added 19.48%	4,502 $2.42 Million
Q2 2023 Jul 10, 2023	SELL	$350.74 - $468.98 $3,858 - $5,158	-11 Reduced 0.29%	3,768 $1.77 Million
Q1 2023 Apr 11, 2023	SELL	$310.63 - $364.82 $68,959 - $80,990	-222 Reduced 5.55%	3,779 $1.3 Million
Q4 2022 Jan 09, 2023	BUY	$321.55 - $374.67 $14,148 - $16,485	44 Added 1.11%	4,001 $0
Q3 2022 Oct 06, 2022	BUY	$296.48 - $337.87 $54,552 - $62,168	184 Added 4.88%	3,957 $1.28 Million
Q2 2022 Jul 08, 2022	BUY	$278.73 - $327.27 $193,996 - $227,779	696 Added 22.62%	3,773 $1.22 Million
Q1 2022 Apr 12, 2022	BUY	$234.69 - $291.66 $57,968 - $72,040	247 Added 8.73%	3,077 $881,000
Q4 2021 Jan 12, 2022	BUY	$224.85 - $279.04 $12,591 - $15,626	56 Added 2.02%	2,830 $782,000
Q3 2021 Oct 07, 2021	BUY	$221.6 - $272.71 $58,059 - $71,450	262 Added 10.43%	2,774 $641,000
Q2 2020 Jul 08, 2020	BUY	$136.42 - $164.18 $1,091 - $1,313	8 Added 0.32%	2,512 $412,000
Q1 2020 Apr 07, 2020	SELL	$119.05 - $147.35 $24,286 - $30,059	-204 Reduced 7.53%	2,504 $347,000
Q4 2019 Jan 09, 2020	BUY	$106.92 - $132.43 $21,811 - $27,015	204 Added 8.15%	2,708 $356,000
Q3 2019 Oct 09, 2019	SELL	$106.79 - $116.16 $24,988 - $27,181	-234 Reduced 8.55%	2,504 $280,000
Q2 2019 Jul 11, 2019	SELL	$110.79 - $129.32 $42,764 - $49,917	-386 Reduced 12.36%	2,738 $303,000
Q1 2019 Apr 05, 2019	BUY	$111.31 - $131.02 $1,224 - $1,441	11 Added 0.35%	3,124 $405,000
Q4 2018 Jan 11, 2019	SELL	$105.9 - $118.64 $5,612 - $6,287	-53 Reduced 1.67%	3,113 $360,000
Q3 2018 Oct 04, 2018	BUY	$85.86 - $107.31 $42,071 - $52,581	490 Added 18.31%	3,166 $340,000
Q2 2018 Jul 10, 2018	BUY	$75.7 - $86.88 $20,211 - $23,196	267 Added 11.08%	2,676 $228,000
Q4 2017 Jan 10, 2018	BUY	$81.94 - $87.89 $1,147 - $1,230	14 Added 0.58%	2,409 $203,000
Q3 2017 Oct 11, 2017	BUY	$77.07 - $85.54 $184,582 - $204,868	2,395	2,395 $205,000

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pure Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pure Financial Advisors, LLC with notifications on news.

Account

Pure Financial Advisors, LLC Eli Lilly & CO Transaction History